<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9888865" created="26/05/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9888865</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="A1" sem="Protein_family_or_group">Tissue factor</term> expression of <term id="T1" lex="human_monocyte" sem="Cell_natural">human monocytes</term> is suppressed by <term id="T2" lex="lysophosphatidylcholine" sem="Lipid">lysophosphatidylcholine</term>.</sentence>
<event KT="Other" id="E1">
<type class="Gene_expression"/>
<theme idref="A1"/>
<clue>Tissue factor <clueType>expression</clueType> <clueLoc>of human monocytes</clueLoc> is suppressed by lysophosphatidylcholine.</clue>
</event>
<event id="E2">
<type class="Negative_regulation"/>
<theme idref="E1"/>
<cause idref="T2"/>
<clue>Tissue factor expression of human monocytes is <clueType>suppressed</clueType> <linkCause>by</linkCause> lysophosphatidylcholine.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The expression of <term id="T3" lex="tissue_factor" sem="Protein_family_or_group">tissue factor</term> (<term id="T4" lex="TF" sem="Protein_family_or_group">TF</term>), the principal initiator of <term id="T5" lex="coagulation" sem="Other">coagulation</term>, is increased during <term id="T6" lex="inflammation" sem="Other">inflammation</term> and <term id="T7" lex="atherosclerosis" sem="Other">atherosclerosis</term>.</sentence>
<event KT="Other" id="E3">
<type class="Gene_expression"/>
<theme idref="T4"/>
<clue>The <clueType>expression</clueType> <linkTheme>of</linkTheme> tissue factor (TF), the principal initiator of coagulation, is increased during inflammation and atherosclerosis.</clue>
</event>
<event KT="Fact" id="E4">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="T6"/>
<clue>The expression of tissue factor (TF), the principal initiator of coagulation, is <clueType>increased</clueType> <linkCause>during</linkCause> inflammation and atherosclerosis.</clue>
</event>
<event KT="Fact" id="E5">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="T7"/>
<clue>The expression of tissue factor (TF), the principal initiator of coagulation, is <clueType>increased</clueType> <linkCause>during</linkCause> inflammation and atherosclerosis.</clue>
</event>
<event KT="Fact" id="E45">
<type class="Positive_regulation"/>
<theme idref="T5"/>
<cause idref="T4"/>
<clue>The expression of tissue factor (TF), the principal <clueType>initiator</clueType> <linkTheme>of</linkTheme> coagulation, is increased during inflammation and atherosclerosis.</clue>
</event>
<sentence id="S3">Both conditions are promoted by <term id="T8" lex="lysophosphatidylcholine" sem="Lipid">lysophosphatidylcholine</term> (<term id="T9" lex="lysoPC" sem="Lipid">lysoPC</term>).</sentence>
<event KT="Fact" id="E6">
<type class="Positive_regulation"/>
<theme idref="E4"/>
<cause idref="T9"/>
<clue><corefTheme>Both conditions</corefTheme> are <clueType>promoted</clueType> <linkCause>by</linkCause> lysophosphatidylcholine (lysoPC).</clue>
</event>
<event KT="Fact" id="E7">
<type class="Positive_regulation"/>
<theme idref="E5"/>
<cause idref="T9"/>
<clue><corefTheme>Both conditions</corefTheme> are <clueType>promoted</clueType> <linkCause>by</linkCause> lysophosphatidylcholine (lysoPC).</clue>
</event>
<sentence id="S4">We observed in the present study that <term id="T10" lex="lysoPC" sem="Lipid">lysoPC</term> (1 to 10 micromol/L) dose-dependently reduced <term id="T11" lex="TF_activity" sem="Other"><term id="T12" lex="TF" sem="Protein_family_or_group">TF</term> activity</term> in <term id="T13" lex="human_monocyte" sem="Cell_natural">human monocytes</term>, as elicited by <term id="T14" lex="lipopolysaccharide" sem="Lipid">lipopolysaccharide</term> (<term id="T15" lex="LPS" sem="Lipid">LPS</term>).</sentence>
<event id="E8">
<type class="Negative_regulation"/>
<theme idref="E9"/>
<cause idref="T10"/>
<clue>We <clueKT>observed</clueKT> in the present study that lysoPC (1 to 10 micromol/L) dose-dependently <clueType>reduced</clueType> TF activity <clueLoc>in human monocytes</clueLoc>, as elicited by lipopolysaccharide (LPS).</clue>
</event>
<event id="E9">
<type class="Positive_regulation"/>
<theme idref="T11"/>
<cause idref="T15"/>
<clue>We observed in the present study that lysoPC (1 to 10 micromol/L) dose-dependently reduced TF activity in human monocytes, as <clueType>elicited</clueType> <linkCause>by</linkCause> lipopolysaccharide (LPS).</clue>
</event>
<sentence id="S5"><term id="T16" lex="lysophosphatidylethanolamine" sem="Organic_compound_other">Lysophosphatidylethanolamine</term> (<term id="T17" lex="lysoPE" sem="Organic_compound_other">lysoPE</term>) and other <term id="T18" lex="lysophospholipid" sem="Lipid">lysophospholipids</term> did not affect <term id="T19" lex="LPS-induced_TF_activity" sem="Other"><term id="T20" lex="LPS" sem="Lipid">LPS</term>-induced <term id="A2" sem="Other">TF activity</term></term> of <term id="T21" lex="human_monocyte" sem="Cell_natural">human monocytes</term>.</sentence>
<event id="E10">
<type class="Positive_regulation"/>
<theme idref="A2"/>
<cause idref="T20"/>
<clue>Lysophosphatidylethanolamine (lysoPE) and other lysophospholipids did not affect LPS-<clueType>induced</clueType> TF activity <clueLoc>of human monocytes</clueLoc>.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E11">
<type class="Regulation"/>
<theme idref="E10"/>
<cause idref="T17"/>
<clue>Lysophosphatidylethanolamine (lysoPE) and other lysophospholipids did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> LPS-induced TF activity of human monocytes.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E12">
<type class="Regulation"/>
<theme idref="E10"/>
<cause idref="T18"/>
<clue>Lysophosphatidylethanolamine (lysoPE) and other lysophospholipids did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> LPS-induced TF activity of human monocytes.</clue>
</event>
<sentence id="S6"><term id="T22" lex="TF_antigen_expression" sem="Other"><term id="A3" sem="Protein_molecule">TF antigen</term> expression</term> as elicited by <term id="T23" lex="LPS" sem="Lipid">LPS</term> was also lowered by <term id="T24" lex="lysoPC" sem="Lipid">lysoPC</term>.</sentence>
<event id="E13">
<type class="Gene_expression"/>
<theme idref="A3"/>
<clue>TF antigen <clueType>expression</clueType> as elicited by LPS was also lowered by lysoPC.</clue>
</event>
<event id="E14">
<type class="Positive_regulation"/>
<theme idref="E13"/>
<cause idref="T23"/>
<clue>TF antigen expression as <clueType>elicited</clueType> <linkCause>by</linkCause> LPS was also lowered by lysoPC.</clue>
</event>
<event id="E15">
<type class="Negative_regulation"/>
<theme idref="E14"/>
<cause idref="T24"/>
<clue>TF antigen expression as elicited by LPS was also <clueType>lowered</clueType> <linkCause>by</linkCause> lysoPC.</clue>
</event>
<sentence id="S7"><term id="T25" lex="phospholipid_analysis" sem="Other">Phospholipid analyses</term> indicated a selective increase in the <term id="T26" lex="lysoPC" sem="Lipid">lysoPC</term> content of the <term id="T27" lex="monocyte" sem="Cell_natural">monocytes</term> after preincubation with the lysophospholipid.</sentence>
<event CL="L2" KT="Analysis" id="E16">
<type class="Positive_regulation"/>
<theme idref="T26"/>
<cause idref="E17"/>
<clue>Phospholipid analyses <clueKT><clueCL>indicated</clueCL></clueKT> a selective <clueType>increase</clueType> <linkTheme>in</linkTheme> the lysoPC content <clueLoc>of the monocytes</clueLoc> <linkCause>after</linkCause> preincubation with the lysophospholipid.</clue>
</event>
<event KT="Method" id="E17">
<type class="Artificial_process"/>
<theme idref="T27"/>
<theme idref="T26"/>
<clue>Phospholipid analyses indicated a selective increase in the lysoPC content of the monocytes after <clueType>preincubation</clueType> <linkTheme>with</linkTheme> <corefTheme>the lysophospholipid</corefTheme>.</clue>
</event>
<sentence id="S8"><term id="T28" lex="lysoPC" sem="Lipid">LysoPC</term> inhibited the <term id="T29" lex="TF_activity" sem="Other">TF activity</term> of <term id="T30" lex="Mono_Mac-6_cell" sem="Cell_cultured">Mono Mac-6 cells</term> to a similar extent as in the <term id="T31" lex="monocyte" sem="Cell_natural">monocytes</term>.</sentence>
<event id="E18">
<type class="Negative_regulation"/>
<theme idref="T29"/>
<cause idref="T28"/>
<clue>LysoPC <clueType>inhibited</clueType> the TF activity <clueLoc>of Mono Mac-6</clueLoc> cells to a similar extent as in the monocytes.</clue>
</event>
<sentence id="S9"><term id="T32" lex="LPS" sem="Lipid">LPS</term> binding to plasma membrane <term id="A4" sem="Protein_family_or_group">receptors</term> and internalization of <term id="T33" lex="LPS" sem="Lipid">LPS</term> into <term id="T34" lex="monocyte" sem="Cell_natural">monocytes</term> were not affected by <term id="T35" lex="lysoPC" sem="Lipid">lysoPC</term>.</sentence>
<event id="E20">
<type class="Binding"/>
<theme idref="A4"/>
<theme idref="T32"/>
<clue>LPS <clueType>binding</clueType> <linkTheme>to</linkTheme> <clueLoc>plasma membrane</clueLoc> receptors and internalization of LPS into monocytes were not affected by lysoPC.</clue>
</event>
<event id="E21">
<type class="Localization"/>
<theme idref="T33"/>
<clue>LPS binding to plasma membrane receptors and <clueType>internalization</clueType> <linkTheme>of</linkTheme> LPS <clueLoc>into monocytes</clueLoc> were not affected by lysoPC.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E22">
<type class="Regulation"/>
<theme idref="E20"/>
<cause idref="T35"/>
<clue>LPS binding to plasma membrane receptors and internalization of LPS into monocytes were <cluePolarity>not</cluePolarity> <clueType>affected</clueType> <linkCause>by</linkCause> lysoPC.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E23">
<type class="Regulation"/>
<theme idref="E21"/>
<cause idref="T35"/>
<clue>LPS binding to plasma membrane receptors and internalization of LPS into monocytes were <cluePolarity>not</cluePolarity> <clueType>affected</clueType> <linkCause>by</linkCause> lysoPC.</clue>
</event>
<sentence id="S10">In contrast, <term id="T36" lex="LPS" sem="Lipid">LPS</term>-mediated nuclear binding of <term id="T37" lex="nuclear_factor-kappaB/Rel" sem="Protein_complex">nuclear factor-kappaB/Rel</term> to a <term id="T38" lex="TF-specific_kappaB_site" sem="DNA_domain_or_region">TF-specific kappaB site</term> was inhibited by <term id="T39" lex="lysoPC" sem="Lipid">lysoPC</term>.</sentence>
<event KT="Other" id="E24">
<type class="Binding"/>
<theme idref="T37"/>
<theme idref="T38"/>
<clue>In contrast, LPS-mediated <clueLoc>nuclear</clueLoc> <clueType>binding</clueType> <linkTheme>of</linkTheme> nuclear factor-kappaB/Rel <linkTheme>to</linkTheme> a TF-specific kappaB site was inhibited by lysoPC.</clue>
</event>
<event KT="Other" id="E25">
<type class="Positive_regulation"/>
<theme idref="E24"/>
<cause idref="T36"/>
<clue>In contrast, LPS-<clueType>mediated</clueType> nuclear binding of nuclear factor-kappaB/Rel to a TF-specific kappaB site was inhibited by lysoPC.</clue>
</event>
<event id="E26">
<type class="Negative_regulation"/>
<theme idref="E25"/>
<cause idref="T39"/>
<clue>In contrast, LPS-mediated nuclear binding of nuclear factor-kappaB/Rel to a TF-specific kappaB site was <clueType>inhibited</clueType> <linkCause>by</linkCause> lysoPC.</clue>
</event>
<sentence id="S11">Induction of <term id="T40" lex="TF_mRNA_expression" sem="Other"><term id="T41" lex="TF_mRNA" sem="RNA_molecule">TF mRNA</term> expression</term> by <term id="T42" lex="LPS" sem="Lipid">LPS</term> tended to be partially reduced by the <term id="T43" lex="lysophospholipid" sem="Lipid">lysophospholipid</term>.</sentence>
<event KT="Other" id="E27">
<type class="Transcription"/>
<theme idref="T41"/>
<clue>Induction of TF mRNA <clueType>expression</clueType> by LPS tended to be partially reduced by the lysophospholipid.</clue>
</event>
<event KT="Other" id="E28">
<type class="Positive_regulation"/>
<theme idref="E27"/>
<cause idref="T42"/>
<clue><clueType>Induction</clueType> <linkTheme>of</linkTheme> TF mRNA expression <linkCause>by</linkCause> LPS tended to be partially reduced by the lysophospholipid.</clue>
</event>
<event KT="Analysis" id="E29">
<type class="Negative_regulation"/>
<theme idref="E28"/>
<cause idref="T39"/>
<clue>Induction of TF mRNA expression by LPS <clueKT>tended</clueKT> to be partially <clueType>reduced</clueType> <linkCause>by</linkCause> <corefCause>the lysophospholipid</corefCause>.</clue>
</event>
<sentence id="S12">Preincubation with <term id="T44" lex="lysoPC" sem="Lipid">lysoPC</term> increased <term id="T45" lex="monocytic_cAMP_level" sem="Other">monocytic <term id="T46" lex="cAMP" sem="Nucleotide">cAMP</term> levels</term>.</sentence>
<event KT="Method" id="E30">
<type class="Artificial_process"/>
<theme idref="T44"/>
<clue><clueType>Preincubation</clueType> <linkTheme>with</linkTheme> lysoPC increased monocytic cAMP levels.</clue>
</event>
<event id="E31">
<type class="Positive_regulation"/>
<theme idref="T46"/>
<cause idref="E30"/>
<clue>Preincubation with lysoPC <clueType>increased</clueType> <clueLoc>monocytic</clueLoc> cAMP <clueType>levels</clueType>.</clue>
</event>
<sentence id="S13">Inhibition of <term id="T47" lex="adenylyl_cyclase" sem="Protein_complex">adenylyl cyclase</term> by pretreatment with <term id="T48" lex="2&apos;-deoxy-3&apos;-adenosine_monophosphate" sem="Nucleotide">2&apos;-deoxy-3&apos;-adenosine monophosphate</term> partially reversed the inhibition of <term id="T49" lex="TF_activity" sem="Other">TF activity</term> promoted by <term id="T50" lex="lysoPC" sem="Lipid">lysoPC</term>.</sentence>
<event id="E32">
<type class="Negative_regulation"/>
<theme idref="T47"/>
<cause idref="T48"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> adenylyl cyclase <linkCause>by</linkCause> pretreatment with 2&apos;-deoxy-3&apos;-adenosine monophosphate partially reversed the inhibition of TF activity promoted by lysoPC.</clue>
<comment>NER: T48 sem mod, Protein_molecule -&gt; Nucleotide</comment></event>
<event id="E34">
<type class="Negative_regulation"/>
<theme idref="E35"/>
<cause idref="E32"/>
<clue>Inhibition of adenylyl cyclase by pretreatment with 2&apos;-deoxy-3&apos;-adenosine monophosphate partially <clueType>reversed</clueType> the inhibition of TF activity promoted by lysoPC.</clue>
</event>
<event id="E35">
<type class="Negative_regulation"/>
<theme idref="T49"/>
<cause idref="T50"/>
<clue>Inhibition of adenylyl cyclase by pretreatment with 2&apos;-deoxy-3&apos;-adenosine monophosphate partially reversed the <clueType>inhibition</clueType> <linkTheme>of</linkTheme> TF activity <linkCause>promoted by</linkCause> lysoPC.</clue>
</event>
<sentence id="S14">In conclusion, <term id="T51" lex="lysoPC" sem="Lipid">lysoPC</term> markedly decreases <term id="T52" lex="LPS-mediated_TF_expression" sem="Other"><term id="T53" lex="LPS" sem="Lipid">LPS</term>-mediated <term id="A5" sem="Protein_family_or_group">TF</term> expression</term> of <term id="T54" lex="human_monocyte" sem="Cell_natural">human monocytes</term>, the effect probably being mediated by both <cons id="C1" lex="(AND transcriptional_mechanism posttranscriptional_mechanism)" sem="(AND Other Other)"><frag id="F1">transcriptional</frag> and <frag id="F2">posttranscriptional</frag> <frag id="F3">mechanisms</frag></cons>.</sentence>
<event KT="Analysis" Manner="High" id="E36">
<type class="Negative_regulation"/>
<theme idref="E38"/>
<cause idref="T51"/>
<clue><clueKT>In conclusion</clueKT>, lysoPC <clueManner>markedly</clueManner> <clueType>decreases</clueType> LPS-mediated TF expression of human monocytes, the effect probably being mediated by both transcriptional and posttranscriptional mechanisms.</clue>
</event>
<event KT="Other" id="E37">
<type class="Gene_expression"/>
<theme idref="A5"/>
<clue>In conclusion, lysoPC markedly decreases LPS-mediated TF <clueType>expression</clueType> <clueLoc>of human monocytes</clueLoc>, the effect probably being mediated by both transcriptional and posttranscriptional mechanisms.</clue>
</event>
<event KT="Other" id="E38">
<type class="Positive_regulation"/>
<theme idref="E37"/>
<cause idref="T53"/>
<clue>In conclusion, lysoPC markedly decreases LPS-<clueType>mediated</clueType> TF expression of human monocytes, the effect probably being mediated by both transcriptional and posttranscriptional mechanisms.</clue>
</event>
<event CL="L1" KT="Analysis" id="E39" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E36"/>
<cause idref="F1" idref1="F3"/>
<clue>In conclusion, lysoPC markedly decreases LPS-mediated TF expression of human monocytes, <corefTheme>the effect</corefTheme> <clueKT><clueCL>probably</clueCL></clueKT> being <clueType>mediated</clueType> <linkCause>by</linkCause> both transcriptional and posttranscriptional mechanisms.</clue>
</event>
<event CL="L1" KT="Analysis" id="E40" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E36"/>
<cause idref="F2" idref1="F3"/>
<clue>In conclusion, lysoPC markedly decreases LPS-mediated TF expression of human monocytes, <corefTheme>the effect</corefTheme> <clueKT><clueCL>probably</clueCL></clueKT> being <clueType>mediated</clueType> <linkCause>by</linkCause> both transcriptional and posttranscriptional mechanisms.</clue>
</event>
<sentence id="S15"><term id="T55" lex="lysoPC" sem="Lipid">LysoPC</term> may thus attenuate activation of <term id="T56" lex="coagulation" sem="Other">coagulation</term> during <term id="T57" lex="inflammation" sem="Other">inflammation</term> and <term id="T58" lex="atherosclerosis" sem="Other">atherosclerosis</term>.</sentence>
<event CL="L1" KT="Analysis" id="E41">
<type class="Negative_regulation"/>
<theme idref="E43"/>
<cause idref="T55"/>
<clue>LysoPC <clueCL>may</clueCL> <clueKT>thus</clueKT> <clueType>attenuate</clueType> activation of coagulation during inflammation and atherosclerosis.</clue>
</event>
<event CL="L1" KT="Analysis" id="E42">
<type class="Negative_regulation"/>
<theme idref="E44"/>
<cause idref="T55"/>
<clue>LysoPC <clueCL>may</clueCL> <clueKT>thus</clueKT> <clueType>attenuate</clueType> activation of coagulation during inflammation and atherosclerosis.</clue>
</event>
<event KT="Other" id="E43">
<type class="Positive_regulation"/>
<theme idref="T56"/>
<cause idref="T57"/>
<clue>LysoPC may thus attenuate <clueType>activation</clueType> <linkTheme>of</linkTheme> coagulation <linkCause>during</linkCause> inflammation and atherosclerosis.</clue>
</event>
<event KT="Other" id="E44">
<type class="Positive_regulation"/>
<theme idref="T56"/>
<cause idref="T58"/>
<clue>LysoPC may thus attenuate <clueType>activation</clueType> <linkTheme>of</linkTheme> coagulation <linkCause>during</linkCause> inflammation and atherosclerosis.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
